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The role of leukocytes in the in vivo dissemination of cytomegalovirus was studied in this experiment. Rat
cytomegalovirus (RCMV) could be transferred to rat granulocytes and monocytes by cocultivation with
RCMV-infected fibroblasts in vitro. Intravenous injection of purified infected granulocytes or monocytes
resulted in a systemic infection in rats, indicating that our model is a powerful tool to gain further insight into
CMV dissemination and the development of new antivirals.
Primary infection or reactivation of human cytomegalovirus
(HCMV) in immunocompromised hosts causes severe morbid-
ity and mortality (18, 26, 27).
During active infection, the presence of the viral matrix
protein pp65 (ppUL83) can be demonstrated in the nucleus of
infected polymorphonuclear cells (PMN) and monocytes
(MNC) by the antigenemia assay (11, 12, 23). PMN have been
shown to be abortively infected, because transcription of the
HCMV genome is blocked after expression of the immediate-
early genes IE1 and IE2 (9, 11).
Although several animal models exist for the study of CMV
infection, little information has been gathered on the in vivo
dissemination of this virus. In a murine model for CMV infec-
tion, viral DNA was detected in mononuclear leukocytes in the
blood of infected mice (1, 22).
We previously postulated that HCMV might employ MNC
and PMN as a vehicle for its dissemination through the body
(15, 21). Using clinical isolates of HCMV, we and others have
shown that PMN and MNC can acquire infective HCMV in
vitro by coculture on infected cells. Subsequently, these leuko-
cytes were able to retransmit the virus to uninfected cells (10,
14, 15, 19, 25). The presence of intact viral particles in these
leukocytes could also be demonstrated with electron micros-
copy (10, 15, 19).
We hypothesized that infected MNC and PMN facilitate the
dissemination of CMV in vivo. To test our hypothesis, we
transferred rat CMV (RCMV) by coculturing from infected
fibroblasts to phagocytes. Subsequently, we investigated the
potential of these infected phagocytes to induce a systemic
RCMV infection in vivo.
Detection of virus in leukocytes of infected rats. The local
board for animal welfare approved all animal experiments de-
scribed. Cell-free RCMV stocks were produced from salivary
gland homogenates from RCMV-infected rats (Harlan, Zeist,
The Netherlands) as described previously (5).
Male PVG rats (n  6; Harlan), 8 weeks of age, received 5
Gy of total body irradiation (TBI), and 106 PFU of cell-free
virus was administered intraperitoneally 16 h after TBI. Irra-
diation was performed consistently in all RCMV infection ex-
periments to allow for maximal viral replication, which is less
pronounced in immunocompetent rats.
At several time points after infection, heparinized blood
samples (400 l) were obtained by orbital punctures. Of each
sample, 200 l was used for DNA isolation according to stan-
dard procedures, and the presence of RCMV UL 54 was de-
tected using a nested PCR as described previously (2) (Fig. 1).
The remaining 200 l of the blood samples was used to isolate
the mononuclear and granulocyte cell fractions. These cell
fractions were cocultivated with uninfected rat lung fibroblasts
(RFL-6; European Collection of Cell Cultures, Salisbury,
United Kingdom) and were checked for virus transmission.
At 1 day postinfection (dpi), all samples were RCMV DNA
negative, meaning that input of virus in the rat circulation was
below detection level. However, starting from day 3, RCMV
DNA became detectable in peripheral blood samples, indicat-
ing that viral replication had taken place. At 7 dpi, RCMV
DNA was detectable in a number of blood samples already
after the first round of nested PCR, indicating a relatively high
viral load. Moreover, the presence of virus DNA could be
demonstrated up to 60 dpi after the second amplification
round. Occasionally, blood samples were also RCMV DNA
negative. This could partially be ascribed to the small amounts
of blood (200 l) that were obtained after orbital puncture
for these time points.
At 7 and 21 dpi, we were able to culture RCMV from both
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PMN and MNC, obtained from the rats infected with cell-free
virus (data not shown). The presence of RCMV was immuno-
histochemically confirmed using monoclonal antibody (MAb)
8 or 35 (16).
These data suggest that, during active RCMV infection, rats
have a DNAemia and viremia that are comparable to those of
a clinical HCMV infection. Earlier studies with murine CMV
(MCMV) also indicated a similar viremia in mice after injec-
tion of recombinant cell-free MCMV, with up to 0.1% of MNC
being MCMV infected (1, 22).
Generation of RCMV-infected PMN and MNC. Purified
PMN and MNC, obtained from uninfected rats (Harlan), were
cocultivated with RCMV-infected RFL-6 cells for 2 h. Subse-
quently, the leukocytes were transferred to empty Transwell
plates (Corning Costar, Cambridge, United Kingdom). The
PMN and MNC were allowed to transmigrate against a che-
motactic gradient of 0.4 M fMLP (Sigma, St. Louis, Mo.) or
1.0 M histamine (Sigma), respectively, for 16 h. The trans-
migrated leukocytes were washed twice with phosphate-buff-
ered saline, assessed for viability by using trypan blue, trans-
ferred to uninfected fibroblasts, incubated for another 2 h, and
removed subsequently. After approximately 2 days, the fibro-
blasts showed cytopathic effect, and after approximately 5 days
plaques had formed. Immunohistochemical staining with MAb
8 or 35 (16) confirmed that transfer of RCMV had taken place
from the infected leukocytes to the fibroblasts (data not
shown).
It proved to be essential that leukocyte populations were
purified by transmigration, since nonpurified leukocyte frac-
tions were contaminated with low levels (0.5%) of infected,
-actin-positive fibroblasts. Cocultivation in vitro or intrave-
nous injection of this low amount of infected fibroblasts into
rats also resulted in a viral infection (data not shown). After
transmigration, the leukocyte populations were devoid of -ac-
tin-positive cells; thus, fibroblasts did not transmigrate.
The purity of the cell fractions was confirmed with immu-
nohistochemical staining with the specific antibodies ED-1 and
His-48 (Pharmingen) for MNC and PMN, respectively. Both
the PMN and the MNC fraction proved to be 95% pure.
Infective cell-free virus that had diffused through the Tran-
swells was removed by washing the purified leukocyte fractions
at least twice with phosphate-buffered saline. The absence of
free virus after washing was confirmed by plaque assay (4).
After cocultivation of PMN and MNC fractions with
RCMV-infected fibroblasts and subsequent purification by
transmigration, the presence of RCMV DNA in these leuko-
cytes could be confirmed by PCR (Fig. 2). Both MNC and
granulocyte fractions were RCMV DNA positive; RCMV
DNA could be detected already after the first round of the
nested PCR.
The presence of intact virus particles in infected fibroblasts
and PMN and MNC was confirmed by transmission electron
microscopy after 12 h of coculture (Fig. 3). Virus particles were
detected in the nucleus and cytoplasm of infected fibroblasts.
In addition, virus appeared to be present in vesicles in infected
PMN and MNC, possibly indicating phagocytosis of virus par-
ticles. Moreover, virus particles were detected in the cytoplasm
and in the nucleus of PMN and MNC, suggesting the possibil-
ity of a productive RCMV infection.
Thus, the generation of RCMV-infected leukocytes, the
presence of intact virus particles in these cells, and transfer of
FIG. 1. Presence of RCMV DNA in whole-blood samples of rats infected with cell-free RCMV. The figure shows viral DNA, amplified by
nested PCR, after loading on an agarose gel and staining with ethidium bromide. Lane 1, marker; lane 2, negative control (H2O); lanes 3 to 19,
time course of blood samples obtained at days 1, 2, 3, 4, 7, 18, 21, 25, 28, 32, 42, 46, 49, 53, 56, 60, and 63, respectively. The blood samples were
RCMV negative at days 4 and 56 p.i. As a control, glyceraldehyde-3-phosphate dehydrogenase DNA was amplified for every sample.
FIG. 2. Presence of RCMV DNA in transmigrated PMN and
MNC. (A) Viral DNA, amplified by nested PCR after loading on an
agarose gel and staining with ethidium bromide. Lane 1, 100-bp mark-
er; lane 2, negative control (H2O); lane 3, PMN; lane 4, MNC; lane 5,
positive control (RCMV-infected fibroblasts). (B) As a control, glyc-
eraldehyde-3-phosphate dehydrogenase DNA was amplified for every
sample.











FIG. 3. Detection of virus particles by transmission electron microscopy in RCMV-infected leukocytes after cocultivation with RCMV-infected
fibroblasts. (A) Presence of virus particles in RCMV-infected MNC. Shown is a detail of a contact point of an MNC with an RCMV-infected fibroblast.
Virus particles (in vesicles) are indicated by arrows. Magnification, 32,000. (B) Overview of an RCMV-infected granulocyte; magnification, 17,000.












the virus to uninfected cells are comparable to data obtained
with HCMV in vitro (9, 11, 12, 23, 25).
Infection of rats with PMN or MNC. Male PVG rats (Har-
lan), 8 weeks of age, received 5 Gy of TBI and were injected in
the tail vein with in vitro RCMV-infected PMN or MNC at
16 h after irradiation. All animals were sacrificed at 4 weeks
postinfection (p.i.). Sera and organs were obtained for a
plaque assay (4) and for histological evaluation on frozen and
paraffin-embedded tissue sections (16).
Intravenous injection of a low dose of infected PMN or
MNC in irradiated rats resulted in a systemic infection. Figure
4 shows the virus titers in spleens (s) and salivary glands (g) at
4 weeks p.i. as determined by a plaque assay. Rats 1 to 4 were
injected with infected PMN, whereas rats 5 to 8 were injected
with infected MNC. Injection of 70,000 PMN resulted in
higher virus titers than did injection with 35,000 PMN. Injec-
tion of 70,000 MNC resulted in similar virus titers as did
injection with 150,000 MNC.
Using a plaque assay, we established that approximately 3%
of the PMN were infected with RCMV, i.e., 1,050 to 2,100 of
the in vivo-administered PMN. During clinical HCMV infec-
tion, it is known that the percentage of infected leukocytes
during active infection is up to 5% (19). Therefore, the in vivo
transmission of RCMV by infected leukocytes proved to be
efficient, because a single injection with a low dose of infected
cells was sufficient to cause a systemic infection. The presence
of RCMV was further confirmed using immunohistochemical
staining on salivary glands with MAbs 8 and 35 (data not
shown).
Generation of HCMV-infected MNC and PMN can be ac-
complished only when low-passage-number clinical isolates are
used (14, 15, 19). Comparison of genomes of clinical isolates
and laboratory strains of HCMV revealed the presence of
approximately 20 additional open reading frames in clinical
isolates, which have been only partially characterized so far (6).
These virulence genes are dispensable for viral replication in
vitro but are beneficial for replication and dissemination in
vivo. Several virally encoded chemokines and chemokine re-
ceptors have been described for HCMV, RCMV, and MCMV
(2, 3, 7, 8, 13, 17, 20, 24). These virally encoded chemokines are
thought to specifically attract MNC and PMN and therefore
may play a crucial role in the dissemination process. Based on
these observations and the data that we have obtained about
this leukocyte-mediated dissemination of RCMV in vivo, we
concur with the hypothesis of Grundy et al. (14) that the
dissemination of CMV by leukocytes, as demonstrated in our
model, plays an important role not only during primary infec-
tions but also during reactivation of CMV.
In conclusion, our study has shown that leukocytes play an
important role in the dissemination of RCMV in vivo. RCMV
DNA was isolated from peripheral blood of rats that were
infected with cell-free virus. RCMV-infected leukocytes could
be generated in vitro, and transfer of these cells resulted in
virus transfer both in vitro and in vivo.
It is likely that HCMV disseminates in humans in a similar
manner during reactivations or primary infection. Therefore,
our model is a powerful tool for further studies of the viral
dissemination process and may prove valuable for the evalua-
tion of new antiviral drugs that can interfere with this dissem-
ination process and subsequent infection.
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